Q3 2013 13F Holders as of 30 Sep 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,209,691
-
Share change
-
+6,312
-
Total reported value
-
$31,950,000
-
Price per share
-
$6.14
-
Number of holders
-
8
-
Value change
-
+$40,581
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q3 2013
As of 30 Sep 2013,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,209,691 shares.
The largest 8 holders included
Partner Fund Management, L.P., Citadel Advisors LLC, Partner Investment Management, L.P., WELLS FARGO & COMPANY/MN, Dynamic Technology Lab Pte Ltd, PDT Partners, LLC, BANK OF MONTREAL /CAN/, and Joel Isaacson & Co., LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.